307 related articles for article (PubMed ID: 17510243)
1. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation.
Kuorelahti A; Rulli S; Huhtaniemi I; Poutanen M
Endocrinology; 2007 Aug; 148(8):3694-703. PubMed ID: 17510243
[TBL] [Abstract][Full Text] [Related]
2. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
[TBL] [Abstract][Full Text] [Related]
3. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin.
Rulli SB; Kuorelahti A; Karaer O; Pelliniemi LJ; Poutanen M; Huhtaniemi I
Endocrinology; 2002 Oct; 143(10):4084-95. PubMed ID: 12239120
[TBL] [Abstract][Full Text] [Related]
4. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
5. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
Michaelson JS; Leder P
Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497
[TBL] [Abstract][Full Text] [Related]
6. Multiple sites of tumorigenesis in transgenic mice overproducing hCG.
Huhtaniemi I; Rulli S; Ahtiainen P; Poutanen M
Mol Cell Endocrinol; 2005 Apr; 234(1-2):117-26. PubMed ID: 15836960
[TBL] [Abstract][Full Text] [Related]
7. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
8. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
[TBL] [Abstract][Full Text] [Related]
9. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin.
Rulli SB; Ahtiainen P; Mäkelä S; Toppari J; Poutanen M; Huhtaniemi I
Endocrinology; 2003 Nov; 144(11):4980-90. PubMed ID: 12960071
[TBL] [Abstract][Full Text] [Related]
10. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
11. Integrin-interacting protein Kindlin-2 induces mammary tumors in transgenic mice.
Li B; Chi X; Song J; Tang Y; Du J; He X; Sun X; Bi Z; Wang Y; Zhan J; Zhang H
Sci China Life Sci; 2019 Feb; 62(2):225-234. PubMed ID: 30460471
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-triggered delays in mammary gland gene expression during the estrous cycle: evidence for a novel timing system.
Silberstein GB; Van Horn K; Hrabeta-Robinson E; Compton J
J Endocrinol; 2006 Aug; 190(2):225-39. PubMed ID: 16899557
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
[TBL] [Abstract][Full Text] [Related]
14. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.
Lin TP; Guzman RC; Osborn RC; Thordarson G; Nandi S
Cancer Res; 1992 Aug; 52(16):4413-9. PubMed ID: 1386556
[TBL] [Abstract][Full Text] [Related]
15. Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors.
Yan L; Della Coletta L; Powell KL; Shen J; Thames H; Aldaz CM; MacLeod MC
PLoS One; 2011 Jan; 6(1):e16515. PubMed ID: 21304988
[TBL] [Abstract][Full Text] [Related]
16. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.
Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R
Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447
[TBL] [Abstract][Full Text] [Related]
17. Mammary gland development is mediated by both stromal and epithelial progesterone receptors.
Humphreys RC; Lydon J; O'Malley BW; Rosen JM
Mol Endocrinol; 1997 Jun; 11(6):801-11. PubMed ID: 9171243
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor inactivation resulted in acceleration in pubertal mammary gland growth, upregulation of ERα expression, and Wnt/β-catenin signaling in female mice.
Gao YR; Walters KA; Desai R; Zhou H; Handelsman DJ; Simanainen U
Endocrinology; 2014 Dec; 155(12):4951-63. PubMed ID: 25076121
[TBL] [Abstract][Full Text] [Related]
20. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
